ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

12,875Medicare Part D Prescriptions Filled, Including Refills
$663K Total Retail Price of All Prescriptions
178 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
95% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
WARFARIN SODIUM 759 704
LEVOTHYROXINE SODIUM 618 585
FUROSEMIDE 550 539
OMEPRAZOLE 459 459
POLYETHYLENE GLYCOL 3350 313 298
CITALOPRAM HBR 312 274
METOPROLOL TARTRATE 291 290
SIMVASTATIN 284 252
AMLODIPINE BESYLATE 271 254
DONEPEZIL HCL 255 250
RISPERIDONE 237 195
NAMENDA 237 233
KLOR-CON M20 216 203
KETOCONAZOLE 194 179
GABAPENTIN 187 137
LANTUS 166 123
SERTRALINE HCL 157 143
ISOSORBIDE MONONITRATE ER 156 156
POTASSIUM CHLORIDE 154 152
ENALAPRIL MALEATE 136 136
ALLOPURINOL 135 126
METOPROLOL SUCCINATE 133 123
NOVOLIN N 127 125
NOVOLIN R 127 96
PREDNISONE 127 119
LISINOPRIL 127 117
DIVALPROEX SODIUM 123 106
CLOPIDOGREL 117 117
ESCITALOPRAM OXALATE 112 107
PLAVIX 110 110
ABILIFY 109 91
PANTOPRAZOLE SODIUM 108 107
ATENOLOL 106 106
TAMSULOSIN HCL 105 98
ALENDRONATE SODIUM 105 84
QUETIAPINE FUMARATE 99 77
MIRTAZAPINE 94 84
BUSPIRONE HCL 93 77
RANITIDINE HCL 91 91
HYDROCODONE-ACETAMINOPHEN 90 88 S3
NITROGLYCERIN PATCH 87 87
ALBUTEROL SULFATE 85 82
TRAZODONE HCL 83 69
IPRATROPIUM-ALBUTEROL 80 77
CEFUROXIME 79 75
DETROL LA 79 79
TRIAMCINOLONE ACETONIDE 69 69
HUMULIN R 67 64
CEPHALEXIN 67 64
GLIPIZIDE 63 63
SANTYL 63 63
DIGOXIN 60 60
CARBIDOPA-LEVODOPA 60 60
ZOLPIDEM TARTRATE 58 45
ERYTHROMYCIN 58 56
CIPROFLOXACIN HCL 53 52
NEXIUM 52 46
DILTIAZEM 24HR CD 52 52
CYMBALTA 52 41
TRAMADOL HCL 50 42
EXELON 50 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.